Project Grant HT94252510213

Award Date 9/1/25
Completion Date 8/31/28
Dollars Obligated $547K
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19122, USA
Similar Awards
The Defense Health Agency awarded a $648,217 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Alabama at Birmingham (UAB) to develop a novel, evidence-based tool to facilitate independence for autistic individuals. The award period runs from September 30, 2024 to September 29, 2027. As part of this project, UAB has subcontracted with Minnesota Healthsolutions Corporation, a woman-owned small business, to contribute expertise in...
This Project Grant award in the amount of $679,085.00 was issued by the Defense Health Agency, a component of the Department of Defense, under the Military Medical Research and Development program (CFDA 12.420). The funding supports research by Temple University-Of The Commonwealth System Of Higher Education, through its division Temple University, to investigate the role of tumor-associated sensory neurons in breast cancer invasion and metastasis. The award period runs from January 15, 2024...
The U.S. Defense Health Agency awarded a $1,999,996 Project Grant to Temple University under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research to identify diagnostic biomarkers of cerebrovascular contributions to cognitive impairment in repeated blast concussion. This 4-year research project, running from June 2025 to May 2029, aims to transform healthcare for military service members, veterans, and the broader public by...
This $3,149,863 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a 4-year evaluation of tele-assessment services for autism spectrum disorder (ASD) in underserved communities. The award was made to Vanderbilt University Medical Center (VUMC), a nonprofit academic medical center in Nashville, Tennessee that has extensive experience supporting federal biomedical research and healthcare initiatives through...
This federal Project Grant award, valued at $763,171.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a pilot clinical trial of an app-based motor skills intervention for reducing motor difficulties in autistic children. The key activities under this grant include adapting and beta testing the PLAY app for autistic preschool children from diverse backgrounds, and conducting a pilot randomized controlled...
The federal Project Grant award of $1,585,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, effective March 1, 2025 through February 28, 2029, supports advanced biomedical research at Temple University-Of The Commonwealth System Of Higher Education aimed at "TARGETING LYMPHATIC CHEMOKINE SIGNALING TO PROMOTE LYMPHANGIOGENESIS FOR THE TREATMENT OF LYMPHEDEMA". The grant funding will enable Temple...
This federal Project Grant award of $435,876.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, effective March 1, 2025 through February 28, 2027, supports advanced biomedical research by Temple University to investigate KIF11, a novel therapeutic target for lymphedema. The research aims to transform healthcare for military service members, veterans, and the broader public by developing innovative solutions to...
The Department of the Army Medical Command awarded a $1,188,750.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Temple University to support research aimed at identifying therapeutic peptide drugs for regenerating visual pathways. The award, effective September 15, 2024, will fund this initiative over a 3-year period through September 14, 2027. As a prominent public research university, Temple University has extensive experience conducting advanced...
This federal Project Grant award of $322,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research at Duke University, a leading private research institution, aimed at investigating the link between paternal preconception toxic exposure and autism risk. The research project will be conducted over a 2-year period from July 1, 2025 to June 30, 2027. This work aligns with the...
The U.S. Defense Health Agency awarded a $2,873,200 Project Grant to The Ohio State University under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "WATER COMPETENCY INTERVENTION FOR CHILDREN ON THE AUTISM SPECTRUM: THE AQUOTIC HYBRID EFFECTIVENESS IMPLEMENTATION TRIAL," will fund research to develop and evaluate a water competency intervention for children on the autism spectrum. The project aims to transform healthcare for military service...

The Project Grant award of $546,681 was granted by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The award supports the "PROJECT IMPACT-AUTISM: INTERNET-BASED MODEL FOR PARAEDUCATORS TO AUGMENT COMPREHENSIVE TREATMENT FOR AUTISTIC LEARNERS" project at Temple University in Philadelphia, PA. The project aims to develop and evaluate an internet-based training model for paraeducators to enhance comprehensive treatment for autistic learners. The award has a performance period from Sep 1, 2025 to Aug 31, 2028. This grant supports research and development efforts to transform healthcare for military service members, veterans, and the broader public through innovative and impactful medical research across diverse domains.

Generated 8/5/25, 3:32 AM